The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering
Open accessAbstract
Mice carrying mutations in multiple genes are traditionally generated by sequential recombination in embryonic stem cells and/or time-consuming intercrossing of mice with a single mutation. The CRISPR/Cas system has been adapted as an efficient gene-targeting technology with the potential for multiplexed genome editing. We demonstrate that CRISPR/Cas-mediated gene editing allows the simultaneous disruption of five genes (Tet1, 2, 3, Sry, Uty--8 alleles) in mouse embryonic stem (ES) cells with high efficiency. Coinjection of Cas9 mRNA and single-guide RNAs (sgRNAs) targeting Tet1 and Tet2 into zygotes generated mice with biallelic mutations in both genes with an efficiency of 80%. Finally, we show that coinjection of Cas9 mRNA/sgRNAs with mutant oligos generated precise point mutations simultaneously in two target genes. Thus, the CRISPR/Cas system allows the one-step generation of animals carrying mutations in multiple genes, an approach that will greatly accelerate the in vivo study of functionally redundant genes and of epistatic gene interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Soon, all sorts of cells and some multicellular organisms would be the object of CRISPR-mediated manipulation, such as human cell cultures, mice, plants, yeasts, and the list goes on [62,63,64,65].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [63]
The cited source says what the claim attributes to it.
In the citing paper
“The need for specific proteins tailored for each gene also makes multiplex gene editing a strenuous task for ZFNs and TALENs, while with Cas9 systems multiple genes can be targeted simply by delivering multiple gRNAs to the cells [63,98].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [63]
The cited source says what the claim attributes to it.
In the citing paper
“focused on the issue of human germline engineering, as the methods have already been demonstrated in mice (6) and monkeys (7).”
From A prudent path forward for genomic engineering and germline gene modification (2015) · cites this paper as [6]
In the citing paper
“However, the desired recombination efficacy often occurs infrequently, which presents enormous challenges for robust applications [61, 82–84].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [61]
In the citing paper
“Recently, the CRISPR/Cas system has been successfully applied to human cells19,20,21,22 and several model organisms for genome editing.23,24,25,26”
From The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo (2014) · cites this paper as [26]
In the citing paper
“DNA sequence recognition requires only a single 20-nt guide RNA and a protospacer adjacent motif, which enables one to rapidly engineer and test a large number of DNA cleavage sites (17)(18)(19)(20).”
From RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection (2014) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Self-citationRNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Efficient genome editing in zebrafish using a CRISPR-Cas system
Hwang, W. Y., Fu, Y., Reyon, D., Maeder, M. L., Tsai, S. Q., Sander, J. D., Peterson, R. T., Yeh, J.-R. J., & Joung, J. K. (2013) · Nature Biotechnology · doi:10.1038/nbt.2501 · Cited by 2,937
Gasiunas, G., Barrangou, R., Horvath, P., & Siksnys, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208507109 · Cited by 2,769
CRISPR/Cas, the Immune System of Bacteria and Archaea
Horvath, P., & Barrangou, R. (2010) · Science · doi:10.1126/science.1179555 · Cited by 2,471
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
Self-citationGenome editing with engineered zinc finger nucleases
Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
Cho, S. W., Kim, S., Kim, J. M., & Kim, J.-S. (2013) · Nature Biotechnology · doi:10.1038/nbt.2507 · Cited by 1,863
RNA-guided genetic silencing systems in bacteria and archaea
Wiedenheft, B., Sternberg, S. H., & Doudna, J. A. (2012) · Nature · doi:10.1038/nature10886 · Cited by 1,851
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 1,005
Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference
Barrangou, R., Birmingham, A., Wiemann, S., Beijersbergen, R. L., Hornung, V., & Smith, A. V. B. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv226 · Cited by 173
Multi-kilobase homozygous targeted gene replacement in human induced pluripotent stem cells
Byrne, S. M., Ortiz, L., Mali, P., Aach, J., & Church, G. M. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1246 · Cited by 158
A modular toolbox for gRNA–Cas9 genome engineering in plants based on the GoldenBraid standard
Vázquez‐Vilar, M., Bernabé‐Orts, J. M., Fernández‐del‐Carmen, A., Ziarsolo, P., Blanca, J., Granell, A., & Orzáez, D. (2016) · Plant Methods · doi:10.1186/s13007-016-0101-2 · Cited by 173
Polygenic Risk Scores in Clinical Psychology: Bridging Genomic Risk to Individual Differences
Bogdan, R., Baranger, D. A. A., & Arpana Agrawal, A. (2018) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050817-084847 · Cited by 169
Dynamic Pluripotent Stem Cell States and Their Applications
Wu, J., & Belmonte, J. C. I. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.10.009 · Cited by 166
Functional implications of a psychiatric risk variant within CACNA1C in induced human neurons
Yoshimizu, T., Pan, J. Q., Mungenast, A. E., Madison, J. M., Su, S. C., Ketterman, J., Öngür, D., McPhie, D. L., Cohen, B. M., Perlis, R. H., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.143 · Cited by 161
Jiang, W., Yang, B., & Weeks, D. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099225 · Cited by 167
Effective gene targeting in rabbits using RNA-guided Cas9 nucleases
Yang, D., Xu, J., Zhu, T., Fan, J., Lai, L., Zhang, J., & Chen, Y. E. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt047 · Cited by 163
Thomas, G. D., Hanna, R. N., Vasudevan, N. T., Hamers, A. A. J., Romanoski, C. E., McArdle, S., Ross, K. D., Blatchley, A., Yoakum, D., Hamilton, B. A., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.011 · Cited by 169
Kishimoto, K., Washio, Y., Yoshiura, Y., Toyoda, A., Ueno, T., Fukuyama, H., Kato, K., & Kinoshita, M. (2018) · Aquaculture · doi:10.1016/j.aquaculture.2018.05.055 · Cited by 163
Parental-to-embryo switch of chromosome organization in early embryogenesis
Collombet, S., Ranisavljevic, N., Nagano, T., Várnai, C., Shisode, T., Leung, W., Piolot, T., Galupa, R., Borensztein, M., Servant, N., et al. (2020) · Nature · doi:10.1038/s41586-020-2125-z · Cited by 164
Gene targeting, genome editing: from Dolly to editors
Tan, W. S., Proudfoot, C., Lillico, S. G., & Whitelaw, B. (2016) · Transgenic Research · doi:10.1007/s11248-016-9932-x · Cited by 163
Bahreini, A., Li, Z., Wang, P., Levine, K. M., Tasdemir, N., Cao, L., Weir, H. M., Puhalla, S. L., Davidson, N. E., Stern, A. M., et al. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0851-4 · Cited by 156
Genome engineering using the CRISPR/Cas system
Horii, T. (2014) · World Journal of Medical Genetics · doi:10.5496/wjmg.v4.i3.69 · Cited by 167
Patterns of CRISPR/Cas9 activity in plants, animals and microbes
Bortesi, L., Zhu, C., Zischewski, J., Pérez, L., Bassié, L., Nadi, R., Forni, G., Lade, S. B., Soto, E., Jin, X., et al. (2016) · Plant Biotechnology Journal · doi:10.1111/pbi.12634 · Cited by 167
Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9
Jehuda, R. B., Shemer, Y., & Binah, O. (2018) · Stem Cell Reviews and Reports · doi:10.1007/s12015-018-9811-3 · Cited by 171
DNMT3A and TET1 cooperate to regulate promoter epigenetic landscapes in mouse embryonic stem cells
Gu, T., Lin, X., Cullen, S. M., Luo, M., Jeong, M., Estecio, M. R., Shen, J., Hardikar, S., Sun, D., Su, J., et al. (2018) · Genome biology · doi:10.1186/s13059-018-1464-7 · Cited by 163
SPOCD1 is an essential executor of piRNA-directed de novo DNA methylation
Zoch, A., Auchynnikava, T., Berrens, R. V., Kabayama, Y., Schöpp, T., Heep, M., Vasiliauskaitė, L., Perez-Rico, Y. A., Cook, A. G., Shkumatava, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2557-5 · Cited by 164
Maternal inheritance of glucose intolerance via oocyte TET3 insufficiency
Chen, B., Du, Y., Zhu, H., Sun, M., Wang, C., Cheng, Y., Pang, H., Ding, G., Gao, J., Tan, Y., et al. (2022) · Nature · doi:10.1038/s41586-022-04756-4 · Cited by 162
Biallelic Mutations in MYORG Cause Autosomal Recessive Primary Familial Brain Calcification
Yao, X., Cheng, X., Wang, C., Zhao, M., Guo, X.-X., Su, H., Lai, L., Zou, X.-H., Chen, X., Zhao, Y., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.05.037 · Cited by 162
Lipid nanoparticles for short interfering RNA delivery
Leung, A. K. K., Tam, Y. Y. C., & Cullis, P. R. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800148-6.00004-3 · Cited by 158
Efficient engineering of a bacteriophage genome using the type I-E CRISPR-Cas system
Kiro, R., Shitrit, D., & Qimron, U. (2014) · RNA Biology · doi:10.4161/rna.27766 · Cited by 157
Generation of Genomic Deletions in Mammalian Cell Lines via CRISPR/Cas9
Bauer, D. E., Canver, M. C., & Orkin, S. H. (2014) · Journal of Visualized Experiments · doi:10.3791/52118 · Cited by 176
Quadrupling efficiency in production of genetically modified pigs through improved oocyte maturation
Yuan, Y., Spate, L. D., Redel, B. K., Tian, Y., Zhou, J., Prather, R. S., & Roberts, R. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1703998114 · Cited by 158
CRISPR interference-based specific and efficient gene inactivation in the brain
Zheng, Y., Shen, W., Zhang, J., Yang, B., Liu, Y., Qi, H., Yu, X., Lu, S., Chen, Y., Xu, Y., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0077-5 · Cited by 162
BMAL1 knockout macaque monkeys display reduced sleep and psychiatric disorders
Qiu, P., Jiang, J., Liu, Z., Cai, Y., Huang, T., Wang, Y., Liu, Q., Nie, Y., Liu, F., Cheng, J., et al. (2019) · National Science Review · doi:10.1093/nsr/nwz002 · Cited by 163
Burgoyne, P. S., & Arnold, A. P. (2016) · Biology of Sex Differences · doi:10.1186/s13293-016-0115-5 · Cited by 154
CRISPR/Cas9 mediated multiplex genome editing and heritable mutagenesis of BmKu70 in Bombyx mori
Ma, S., Chang, J., Wang, X., Liu, Y., Zhang, J., Lü, W., Gao, J., Shi, R., Zhao, P., & Xia, Q. (2014) · Scientific Reports · doi:10.1038/srep04489 · Cited by 158
Genetic engineering of modular PKSs: from combinatorial biosynthesis to synthetic biology
Weissman, K. J. (2015) · Natural Product Reports · doi:10.1039/c5np00109a · Cited by 156
CrEdit: CRISPR mediated multi-loci gene integration in Saccharomyces cerevisiae
Ronda, C., Maury, J., Jakočiūnas, T., Jacobsen, S. A. B., Germann, S. M., Harrison, S. J., Borodina, I., Keasling, J. D., Jensen, M. K., & Nielsen, A. T. (2015) · Microbial Cell Factories · doi:10.1186/s12934-015-0288-3 · Cited by 156
CRISPR/Cas9-mediated genome editing in a reef-building coral
Cleves, P. A., Strader, M. E., Bay, L. K., Pringle, J. R., & Matz, M. V. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722151115 · Cited by 160
Current status and perspectives of genome editing technology for microalgae
Jeon, S., Lim, J.-M., Lee, H.-G., Shin, S.-E., Kang, N. K., Park, Y.-I., Oh, H.-M., Jeong, W.-J., Jeong, B.-R., & Chang, Y. K. (2017) · Biotechnology for Biofuels · doi:10.1186/s13068-017-0957-z · Cited by 154
A Simple CRISPR/Cas9 System for Multiplex Genome Editing in Rice
Wang, C., Shen, L., Fu, Y., Yan, C., & Wang, K. (2015) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2015.09.011 · Cited by 154
Multiplex Conditional Mutagenesis Using Transgenic Expression of Cas9 and sgRNAs
Yin, L., Maddison, L. A., Li, M., Kara, N., LaFave, M. C., Varshney, G. K., Burgess, S. M., Patton, J. G., & Chen, W. (2015) · Genetics · doi:10.1534/genetics.115.176917 · Cited by 160
Mouse Genome Editing Using the CRISPR/Cas System
Harms, D. W., Quadros, R. M., Seruggia, D., Ohtsuka, M., Takahashi, G., Montoliu, L., & Gurumurthy, C. B. (2014) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg1507s83 · Cited by 153
Optimization of Genome Engineering Approaches with the CRISPR/Cas9 System
Li, K., Wang, G., Andersen, T., Zhou, P., & Pu, W. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105779 · Cited by 123
Genome-editing technologies and their potential application in horticultural crop breeding
Xiong, J., Ding, J., & Li, Y. (2015) · Horticulture Research · doi:10.1038/hortres.2015.19 · Cited by 152
Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish
Albadri, S., Bene, F. D., & Revenu, C. (2017) · Methods · doi:10.1016/j.ymeth.2017.03.005 · Cited by 152
Generating mouse models for biomedical research: technological advances
Gurumurthy, C. B., & Lloyd, K. C. K. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.029462 · Cited by 166
Dual sgRNA-directed gene knockout using CRISPR/Cas9 technology in Caenorhabditis elegans
Chen, X., Xu, F., Zhu, C., Ji, J., Zhou, X., Feng, X., & Guang, S. (2014) · Scientific Reports · doi:10.1038/srep07581 · Cited by 152
Araki, M., & Ishii, T. (2014) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-12-108 · Cited by 150
Pees, B., Yang, W., Zárate-Potes, A., Hinrich Schulenburg, Y., & Dierking, K. (2015) · Journal of Innate Immunity · doi:10.1159/000441475 · Cited by 150
Kim, S. K., Han, G. H., Seong, W., Kim, H., Kim, S.-W., Lee, D., & Lee, S. (2016) · Metabolic Engineering · doi:10.1016/j.ymben.2016.08.006 · Cited by 150
Liu, J., Gaj, T., Patterson, J. T., Sirk, S. J., & Barbas, C. F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085755 · Cited by 151
High-efficiency targeted editing of large viral genomes by RNA-guided nucleases
Bi, Y., Sun, L., Gao, D., Ding, C., Li, Z., Li, Y., Cun, W., & Li, Q. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004090 · Cited by 148
Dual sgRNAs facilitate CRISPR/Cas9‐mediated mouse genome targeting
Zhou, J., Wang, J., Shen, B., Chen, L., Yang, S., Yang, J., Zhang, W., Tian, X., & Huang, X. (2014) · FEBS Journal · doi:10.1111/febs.12735 · Cited by 148
Loss of motoneuron-specific microRNA-218 causes systemic neuromuscular failure
Amin, N. D., Bai, G., Klug, J. R., Bonanomi, D., Pankratz, M. T., Gifford, W. D., Hinckley, C. A., Sternfeld, M. J., Driscoll, S. P., Dominguez, B., et al. (2015) · Science · doi:10.1126/science.aad2509 · Cited by 154
Rapid and efficient one-step generation of paired gRNA CRISPR-Cas9 libraries
Vidigal, J. A., & Ventura, A. (2015) · Nature Communications · doi:10.1038/ncomms9083 · Cited by 147
Tissue-specific genome editing in Ciona embryos by CRISPR/Cas9
Stolfi, A., Gandhi, S., Salek, F., & Christiaen, L. (2014) · Development · doi:10.1242/dev.114488 · Cited by 137
Switching on sex: transcriptional regulation of the testis-determining gene Sry
Larney, C., Bailey, T. L., & Koopman, P. A. (2014) · Development · doi:10.1242/dev.107052 · Cited by 148
Jacobi, A. M., Rettig, G. R., Turk, R., Collingwood, M. A., Zeiner, S. A., Quadros, R. M., Harms, D. W., Bonthuis, P. J., Gregg, C. J., Ohtsuka, M., et al. (2017) · Methods · doi:10.1016/j.ymeth.2017.03.021 · Cited by 142
Li, P., Estrada, J., Burlak, C., Montgomery, J. B., Butler, J. R., Miyashiro, R., Wang, Z., Paris, L. L., Blankenship, R. L., Downey, S. M., et al. (2014) · Xenotransplantation · doi:10.1111/xen.12131 · Cited by 146
Direct activation of human and mouse Oct4 genes using engineered TALE and Cas9 transcription factors
Hu, J., Lei, Y., Wong, W.-K., Liu, S., Lee, K.-C., He, X., You, W., Zhou, R., Guo, J., Chen, X., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku109 · Cited by 145
The short-lived African turquoise killifish: an emerging experimental model for ageing
Kim, Y., Nam, H. G., & Valenzano, D. R. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.023226 · Cited by 146
Pacher, M., & Puchta, H. (2016) · The Plant Journal · doi:10.1111/tpj.13469 · Cited by 152
Genome Editing in Plants: An Overview of Tools and Applications
Kamburova, V., Nikitina, E. V., Shermatov, S. E., Buriev, Z. T., Kumpatla, S. P., Emani, C., & Abdurakhmonov, I. Y. (2017) · International Journal of Agronomy · doi:10.1155/2017/7315351 · Cited by 148
CETCh-seq: CRISPR epitope tagging ChIP-seq of DNA-binding proteinsPreprint
Savic, D., Partridge, E. C., Newberry, K. M., Smith, S. B., Meadows, S. K., Roberts, B. S., Mackiewicz, M., Mendenhall, E. M., & Myers, R. (2015) · Genome Research · doi:10.1101/gr.193540.115 · Cited by 141
Delivery of CRISPR/Cas9 for therapeutic genome editing
Xu, X., Wan, T., Xin, H., Li, D., Pan, H., Wu, J., & Ping, Y. (2019) · The Journal of Gene Medicine · doi:10.1002/jgm.3107 · Cited by 134
Opportunities and challenges in modeling human brain disorders in transgenic primates
Jennings, C. G. B., Landman, R., Zhou, Y., Sharma, J., Hyman, J. B., Movshon, J. A., Qiu, Z., Roberts, A., Roe, A. W., Wang, X., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4362 · Cited by 145
Self-citationRong, Y., Ji, S., Zhu, Y., Wu, Y., Shen, L., & Fan, H. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz863 · Cited by 143
Epigenetic regulator function through mouse gastrulation
Grosswendt, S., Kretzmer, H., Smith, Z. D., Kumar, A. S., Hetzel, S., Wittler, L., Klages, S., Timmermann, B., Mukherji, S., & Meissner, A. (2020) · Nature · doi:10.1038/s41586-020-2552-x · Cited by 138
Large Genomic Fragment Deletions and Insertions in Mouse Using CRISPR/Cas9
Zhang, L., Jia, R., Palange, N. J., Satheka, A. C., Togo, J., An, Y., Mabwi, H. A., Ban, L., Ji, Y., Jin, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120396 · Cited by 142
Li, J., Shou, J., Guo, Y., Tang, Y., Wu, Y., Jia, Z., Zhai, Y., Chen, Z., Xu, Q., & Wu, Q. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv016 · Cited by 144
Schimmel, J., Kool, H., van Schendel, R., & Tijsterman, M. (2017) · EMBO Journal · doi:10.15252/embj.201796948 · Cited by 128
Stepwise cell fate decision pathways during osteoclastogenesis at single-cell resolution
Tsukasaki, M., Huynh, N. C., Okamoto, K., Muro, R., Terashima, A., Kurikawa, Y., Komatsu, N., Pluemsakunthai, W., Nitta, T., Abe, T., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00318-y · Cited by 142
Optimizing the DNA Donor Template for Homology-Directed Repair of Double-Strand Breaks
Song, F., & Stieger, K. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.02.006 · Cited by 140
Myocardin in biology and disease
Miano, J. M. (2015) · Journal of Biomedical Research · doi:10.7555/jbr.29.20140151 · Cited by 148
Small molecules enhance CRISPR/Cas9-mediated homology-directed genome editing in primary cells
Li, G., Zhang, X., Zhong, C., Mo, J., Quan, R., Yang, J., Liu, D., Li, Z., Yang, H., & Wu, Z. (2017) · Scientific Reports · doi:10.1038/s41598-017-09306-x · Cited by 139
Self-citationIntervertebral disc degeneration and how it leads to low back pain
Diwan, A. D., & Melrose, J. (2022) · JOR Spine · doi:10.1002/jsp2.1231 · Cited by 143
Generation of improved humanized mouse models for human infectious diseases
Brehm, M. A., Wiles, M. V., Greiner, D. L., & Shultz, L. D. (2014) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.02.011 · Cited by 137
Microhomologies are prevalent at Cas9-induced larger deletions
Owens, D. D. G., Caulder, A., Frontera, V., Harman, J. R., Allan, A. J., Bucakci, A., Greder, L., Codner, G. F., Hublitz, P., McHugh, P. J., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz459 · Cited by 136
Efficient homologous recombination-mediated genome engineering in zebrafish using TALE nucleases
Shin, J., Chen, J., & Solnica‐Krezel, L. (2014) · Development · doi:10.1242/dev.108019 · Cited by 135
Grompe, M., & Strom, S. C. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.09.009 · Cited by 133
Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing
Han, H. A., Pang, J. K. S., & Soh, B.-S. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01893-z · Cited by 134
Gu, S., Tan, J., Li, Q., Liu, S., Ma, J., Zheng, Y., Liu, J., Bi, W., Sha, P., Li, X., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.316388 · Cited by 135
Self-citationDelivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9
LaFountaine, J. S., Fathe, K., & Smyth, H. D. C. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.08.029 · Cited by 111
Surrogate reporter-based enrichment of cells containing RNA-guided Cas9 nuclease-induced mutations
Ramakrishna, S., Cho, S. W., Kim, S., Song, M., Gopalappa, R., Kim, J., & Kim, S. (2014) · Nature Communications · doi:10.1038/ncomms4378 · Cited by 134
Repurposing CRISPR/Cas9 for in situ functional assaysPreprint
Malina, A., Mills, J. R., Cencic, R., Yan, Y., Fraser, J., Nederveen-Schippers, L. M., Paquet, M., Dostie, J., & Pelletier, J. (2013) · Genes & Development · doi:10.1101/gad.227132.113 · Cited by 132
Promoting Cas9 degradation reduces mosaic mutations in non-human primate embryos
Tu, Z., Yang, W., Yan, S., Yin, A., Gao, J., Liu, X., Zheng, Y., Zheng, J., Li, Z., Yang, S., et al. (2017) · Scientific Reports · doi:10.1038/srep42081 · Cited by 135
Kumlehn, J., Pietralla, J., Hensel, G., Pacher, M., & Puchta, H. (2018) · Journal of Integrative Plant Biology · doi:10.1111/jipb.12734 · Cited by 142
Genotyping with CRISPR-Cas-derived RNA-guided endonucleases
Kim, J. M., Kim, D., Kim, S., & Kim, J. (2014) · Nature Communications · doi:10.1038/ncomms4157 · Cited by 129
CRISPR/Cas9 mediated genome engineering in Drosophila
Bassett, A. R., & Liu, J. (2014) · Methods · doi:10.1016/j.ymeth.2014.02.019 · Cited by 131
One-step generation of triple knockout CHO cell lines using CRISPR/Cas9 and fluorescent enrichment
Grav, L. M., Lee, J. S., Gerling, S., Kallehauge, T. B., Hansen, A. H., Kol, S., Lee, G. M., Pedersen, L. E., & Kildegaard, H. F. (2015) · Biotechnology Journal · doi:10.1002/biot.201500027 · Cited by 131
Engineering large animal models of human disease
Whitelaw, B., Sheets, T. P., Lillico, S. G., & Telugu, B. P. V. L. (2015) · The Journal of Pathology · doi:10.1002/path.4648 · Cited by 138
The three-dimensional genome: regulating gene expression during pluripotency and development
Andrey, G., & Mundlos, S. (2017) · Development · doi:10.1242/dev.148304 · Cited by 134
Liu, F., Chen, J., Wang, P., Li, H., Zhou, Y., Liu, H., Liu, Z., Zheng, R., Wang, L., Yang, H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06836-4 · Cited by 136
Self-citationCerbini, T. A., Funahashi, R., Luo, Y., Liu, C., Park, K., Rao, M. S., Malik, N., & Zou, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116032 · Cited by 127
Selective disruption of an oncogenic mutant allele by CRISPR/Cas9 induces efficient tumor regression
Koo, T., Yoon, A. R., Cho, H., Bae, S., Yun, C., & Kim, J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx490 · Cited by 130
Chen, S., Sun, S., Moonen, D. P. I., Lee, C., Lee, A. Y.-F., Schaffer, D. V., & He, L. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.103 · Cited by 133
Loureiro, A., & da Silva, G. J. (2019) · Antibiotics · doi:10.3390/antibiotics8010018 · Cited by 129
Mammalian Reverse Genetics without Crossing Reveals Nr3a as a Short-Sleeper Gene
Sunagawa, G. A., Sumiyama, K., Ukai‐Tadenuma, M., Perrin, D., Fujishima, H., Ukai, H., Nishimura, O., Shi, S., Ohno, R.-I., Narumi, R., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2015.12.052 · Cited by 126
Precision medicine: the foundation of future cancer therapeutics
Shin, S. H., Bode, A. M., & Dong, Z. (2017) · npj Precision Oncology · doi:10.1038/s41698-017-0016-z · Cited by 132
Efficient mouse genome engineering by CRISPR-EZ technology
Modzelewski, A. J., Chen, S., Willis, B., Lloyd, K. C. K., Wood, J. A., & He, L. (2018) · Nature Protocols · doi:10.1038/nprot.2018.012 · Cited by 125
Claussnitzer, M., Dankel, S. N., Klocke, B., Grallert, H., Glunk, V., Berulava, T., Lee, H., Oskolkov, N., Fadista, J., Ehlers, K., et al. (2014) · Cell · doi:10.1016/j.cell.2013.10.058 · Cited by 133
CEP290 gene transfer rescues Leber congenital amaurosis cellular phenotype
Burnight, E. R., Wiley, L. A., Drack, A. V., Braun, T. A., Anfinson, K. R., Kaalberg, E. E., Halder, J. A., Affatigato, L. M., Mullins, R. F., Stone, E. M., et al. (2014) · Gene Therapy · doi:10.1038/gt.2014.39 · Cited by 128
Gene editing for cell engineering: trends and applications
Gupta, S. K., & Shukla, P. (2016) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2016.1214557 · Cited by 135
CRISPR/Cas9 gene-editing: Research technologies, clinical applications and ethical considerations
Memi, F., Ntokou, A., & Papangeli, I. (2018) · Seminars in Perinatology · doi:10.1053/j.semperi.2018.09.003 · Cited by 134
Dead Cas Systems: Types, Principles, and Applications
Brezgin, S., Kostyusheva, A., Kostyushev, D. S., & Chulanov, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236041 · Cited by 135
Biomedical applications of mRNA nanomedicine
Xiong, Q., Lee, G. Y., Ding, J., Li, W., & Shi, J. (2018) · Nano Research · doi:10.1007/s12274-018-2146-1 · Cited by 125
CRISPR/Cas9‐mediated genome editing: From basic research to translational medicine
Jacinto, F. V., Link, W., & Ferreira, B. I. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14916 · Cited by 135
Metadata
- Authors
- Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Broad Institute (US)
- Corresponding author
- Jaenisch, Rudolf
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 153
- Issue
- 4
- Pages
- 910-918
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC3969854
- OpenAlex
- W2170039745
- Cited by
- 3,495
- References
- 35
- Citations by year
- 2026: 63 · 2025: 94 · 2024: 166 · 2023: 203 · 2022: 210 · 2021: 239 · 2020: 286 · 2019: 299 · 2018: 332 · 2017: 352 · 2016: 392 · 2015: 362 · 2014: 359 · 2013: 134
- FWCI
- 186.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-nd)
- PMC
- Funders
- Damon Runyon Cancer Research Foundation
- National Institutes of Health (2r01ca084198-10)
- National Institute of Mental Health (DP1MH100706)
- National Cancer Institute (R01-CA084198)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R37HD045022)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- CRISPR/Cas genome editing, multiplexed genome editing, mouse mutagenesis, TET1, TET2, TET3, SRY, UTY, biallelic variants, single guide RNA, zygote injection, mouse embryonic stem cells
- MeSH terms
- Animals, Base Sequence, Female, Male, Mice, Inbred C57BL, Mice, Inbred DBA, Molecular Sequence Data, Gene Targeting, Mice, Embryonic Stem Cells, RNA, Small Untranslated
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
